Target intelligence / Profile preview

CD206 and Toll-Like Receptors (CD206 and TLRs)

Target
CD206 and TLRs
Molecular classification
Receptor, C-type lectin receptor (CLR), Transmembrane protein, Pattern recognition receptor
01

Overview

Note on target definition: The original query "CD206 and Toll-Like Receptors" improperly merges two distinct protein families; for structured annotation, these should be handled as individual targets, given their unique molecular, functional, and pharmacological characteristics. Their interaction is a subject of immunological research but they are not a single molecular entity. CD206 (Mannose receptor) is a type I transmembrane C-type lectin receptor found mainly on macrophages, dendritic cells, and endothelial cells. It binds terminal mannose, N-acetylglucosamine, and fucose residues on pathogens or glycoproteins, mediating their endocytosis and removal, and plays a regulatory role in innate and adaptive immunity. It is involved in immunosurveillance and tissue homeostasis, and high expression is observed in tissue pathology, notably in tumor-associated macrophages. Soluble forms of CD206 are shed in disease and serve as biomarkers. Toll-like receptors (TLRs) are a family of pattern recognition receptors critical for detecting microbial structures (PAMPs—pathogen-associated molecular patterns). They are classified by their specificity (TLR1-10 in humans), detect a wide range of microbial and host danger signals, and initiate downstream signaling pathways that drive both innate and adaptive immune responses. They are widely expressed in various immune and non-immune cells, and their signaling shapes T cell polarization, cytokine secretion, and the outcome of infections or inflammatory conditions.

Other names
Mannose receptorMRMRC1Cluster of Differentiation 206TLRsTLR1TLR2TLR3TLR4etc.
02

Mechanism of action

For CD206: Ligand (mannose/complex glycans) binding triggers endocytosis/phagocytosis, promotes antigen uptake/presentation, mediates immune regulation; some drugs block ligand binding or modulate receptor recycling. For Toll-like receptors: Ligand (PAMP/DAMP) binding triggers downstream NF-κB and MAPK pathways, resulting in cytokine production and immune cell activation; some drugs act as agonists to boost immunity or antagonists to dampen inflammation.

03

Biological functions

Pathogen recognitionEndocytosisPhagocytosisImmune homeostasisAntigen presentationRegulation of inflammationSignal transductionCytokine productionInitiation of innate and adaptive immune responsesImmune cell activation
04

Disease associations

InfectionInflammationCancerTissue repairLiver fibrosisAutoimmune diseaseSepsis
05

Safety considerations

For CD206: Broad involvement in host immunity poses risk for unintended immunosuppression or activation, potential for enhanced pathogen uptake, off-target effects.For Toll-like receptors: Excessive activation can drive systemic inflammation, autoimmunity, or cytokine storm; blockade may increase infection risk.
06

Interacting drugs

Multivalent glycopolymers targeting CD206, e.g., SO4-3-Gal glycopolymers

2 more in the full profile.

07

Biomarkers

Soluble CD206 (sCD206) in serum (a biomarker for macrophage activation and severity in infections such as community-acquired pneumonia)Various TLR expression levels on immune cells as biomarkers for immune status, disease risk, or response to immunotherapy

Beyond the preview

Go deeper on CD206 and Toll-Like Receptors (CD206 and TLRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD206 and Toll-Like Receptors (CD206 and TLRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call